| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $8.17B | $8.32B | $7.83B | $7.04B | $6.55B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $2.06B | $2.01B | $1.94B | $1.72B | $1.55B |
| Operating Income | $1.07B | $1.12B | $1.07B | $1.12B | $1.33B |
| Interest Expense | $80.00M | $76.00M | $76.00M | $85.00M | $94.00M |
| Tax Expense | $231.00M | $237.00M | $221.00M | $225.00M | $254.00M |
| Net Income | $842.00M | $887.00M | $852.00M | $898.00M | $2.00B |
| EPS (basic) | 10.0800 | 10.5700 | 10.0600 | 10.5500 | 23.4400 |
| EPS (diluted) | 10.0800 | 10.5700 | 10.0500 | 10.5300 | 23.3000 |
| Shares (diluted) | $83.50M | $83.90M | $84.80M | $85.30M | $85.60M |